Male Infertility Market Expansion Is Opening New Pathways For Strategic Investment
Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Male Infertility Market Forecast: What Market Value Is Expected By 2030?
The male infertility market has seen robust expansion in recent years, with projections indicating an increase from $4.33 billion in 2025 to $4.57 billion in 2026, reflecting a compound annual growth rate (CAGR) of 5.6%. This historic growth has been driven by factors such as a global decline in sperm quality, a higher incidence of lifestyle-related infertility, the proliferation of fertility clinics, broader societal acceptance of assisted reproductive technologies, and improvements in semen analysis methodologies.
The market for male infertility is anticipated to experience robust expansion over the coming years. By 2030, it is projected to reach a valuation of $5.76 billion, reflecting a compound annual growth rate (CAGR) of 6.0%. This growth during the forecast period is driven by a combination of factors, including climbing infertility rates linked to environmental influences, a surge in demand for IVF and ICSI procedures, progress in fertility diagnostic technologies, heightened awareness surrounding male reproductive health, and the broadening of infertility treatment access in developing regions. Key developments shaping the future outlook include the growing adoption of assisted reproductive technologies, the increased application of sophisticated sperm diagnostic tests, a stronger emphasis on hormonal and targeted drug treatments, the advancement of microsurgical interventions for male infertility, and greater awareness coupled with earlier detection of this condition.
Download A Free Sample Report For Comprehensive Market Insights:
Male Infertility Market Expansion Supported By Key Demand Factors
The male infertility market is expected to be driven forward by rising stress levels in the coming years. Stress levels represent the degree of emotional, physical, or mental pressure individuals encounter when facing demanding situations. This increase in stress is fueled by growing work demands, where continuous pressure and high expectations result in burnout, disrupting mental health and work-life balance. Higher stress can upset hormonal equilibrium, reduce sperm quality, and impair sexual performance, all of which contribute to male infertility. Persistent stress alters cortisol and testosterone levels, leading to a higher incidence of infertility cases. For example, the American Psychiatric Association, a US-based organization representing psychologists, reported in May 2024 that 43% of adults in the US felt more anxious in 2024, up from 37% in 2023 and 32% in 2022, demonstrating a steady rise in anxiety. As a result, these escalating stress levels are fueling expansion in the male infertility market.
Male Infertility Market Segment Outlook: Which Categories Are Expanding The Fastest?
The male infertility market covered in this report is segmented –
1) By Treatment Type: Medication, Surgery, Assisted Reproductive Technology
2) By Test Type: Sperm Agglutination, Deoxyribonucleic Acid Fragmentation Technique, Oxidative Stress Analysis, Computer Assisted Semen Analysis, Sperm Penetration Assay, Other Test Types
3) By Distribution Channel: Hospitals Pharmacies, Pharmacies And Drug Stores, Online Pharmacies
4) By End-User: Hospitals And Clinics, Fertility Centers, Research Institutes, Other End-Users
Subsegments:
1) By Medication: Hormone Treatments, Gonadotropins, Antibiotics, Antiestrogens, Dopamine Agonists
2) By Surgery: Varicocelectomy, Vasovasostomy, Epididymovasostomy, Transurethral Resection of the Ejaculatory Duct (TURED), Sperm Retrieval Procedures
3) By Assisted Reproductive Technology (ART): In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), Sperm Donation, Cryopreservation Of Sperm
Male Infertility Market Growth Trends Influencing Competitive Dynamics
Major players in the male infertility market are increasingly turning to strategic partnerships as a key approach to expand access to advanced fertility treatments on a global scale. Such collaborations involve organizations pooling their resources and expertise to work toward common goals, fostering innovation, broadening market reach, and strengthening research and development activities. A notable example from June 2024 is Ferring Pharmaceuticals, a Swiss pharmaceutical firm, which joined forces with Posterity Health, a US-based male fertility clinic, to launch a dedicated male fertility program on Ferring’s Fertility Out Loud platform. This initiative is designed to educate men about their reproductive health by providing a confidential online assessment and educational materials created by reproductive urologists. It aims to help men better understand their fertility status while reducing the stigma associated with male infertility, a condition that contributes to as much as 50% of all infertility cases. By encouraging early intervention, the program seeks to empower men to take proactive steps, potentially improving the couple’s journey toward parenthood through the convenient and timely use of digital tools and telehealth services.
Male Infertility Market Key Companies And Competitive Benchmarking
Major companies operating in the male infertility market are Novartis AG, Amgen Inc., Teva Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., NYU Langone Hospitals, Sun Pharmaceutical Industries Ltd., Cipla Limited, Ferring Pharmaceuticals, Fortis Healthcare, Vitrolife, Max Healthcare, CinnaGen Co., Aytu BioScience Inc., Zydus Hospitals and Healthcare Research Private Limited, Apricus Biosciences Inc., SCSA Diagnostics Inc., Andrology Solutions, Halotech DNA, Indira IVF, Conduit Pharmaceuticals, Shree IVF Clinics
Access The Complete Male Infertility Market Report:
Male Infertility Market Geographic Distribution And Regional Opportunities
North America was the largest region in the male infertility market in 2025. The regions covered in the male infertility market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
